Bruno Larvol founded The Larvol Group in 2004. The company offers innovative intelligence solutions to 9 of the top 10 pharmaceutical companies. Over the past 18 years, Mr. Larvol has built a successful track record in the pharmaceutical field with industry leaders such as IBM Healthcare Consulting (The Wilkerson Group), Sandoz (Novartis), and Lehman Brothers. He holds an MBA with distinction from the Kellogg School of Management, an MS in biotechnology from Northwestern University, and a BA summa cum laude from Sorbonne
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)